Immune
Primary Immunodeficiency
search
Primary Immunodeficiency
, Immunodeficiency, Primary Immune Deficiency Disorder, Immunocompromised
See Also
Immune System
Humoral Immunity
(
Immunoglobulin
)
T-Lymphocyte
B-Lymphocyte
Antigen Processing
Complement Pathway
Epidemiology
Normal children have recurrent infections
Average child has 5-6
Upper Respiratory Infection
s/year
Unlucky children (5%) have 11-12 URIs per year
Otitis Media
complicates URIs in 30-50% of cases
Primary Immunodeficiency
Prevalence
United States: 83 per 100,000
Australia: 12 per 100,000
Sweden: 0.35 per 100,000
Types
Primary Immunodeficiency
Rare immune disorders of childhood
Gene
tic abnormalities affecting
T-Cell
s, B-Cells,
Phagocyte
s or Complement
Humoral Immunodeficiency
(
B-Cell Disorder
,
Immunoglobulin Disorder
,
Antibody Disorder
)
Cell-Mediated Immunodeficiency
(
T-Cell Disorder
)
Phagocytic Immunodeficiency
Complement Disorder
s
Secondary Immunodeficiency (Acquired Immunodeficiency)
Asplenism
(e.g. splenectomy,
Sickle Cell Anemia
)
Immunosuppressant
Corticosteroid
s
Chemotherapy
Transplant Anti-Rejection Drugs
Autoimmune Condition
Agents (e.g.
Rheumatoid Arthritis Remittive Agent
s,
Biological Agent
)
Malnutrition
Cancer involving
Bone Marrow
Radiation Therapy
HIV Infection
or
AIDS
Presents similarly to T-Cell Immunodeficiency Disorder
Causes
Antibody
or humoral (
B-Cell Disorder
): 78% of cases in U.S. (55% in Europe)
Gene
ral
Present after 3 months of age (when maternal antibodies are no longer present)
B Cell
deficiency or maturation defect results in
Antibody
deficiency
Recurrent respiratory (ears, sinus, lungs) infections with encapsulated organisms
Streptococcus Pneumoniae
Haemophilus
Influenza
e
No B-Cells:
Agammaglobulinemia
X-Linked Agammaglobulinemia
or XLA (84% of
Agammaglobulinemia
cases in Europe)
Bruton
Tyrosine Kinase
defect (Btk gene) results in defective B-Cell maturation
Absent peripheral B-Cells results in very low serum IgG, IgA and IgM
Infants may have no
Tonsil
s or
Lymph Node
s on exam
Severe respiratory infections with
Encapsulated Bacteria
(e.g. pneumococcus, H.
Influenza
e)
Chronic Diarrhea
(echoviruses and coxsackie virus), recurrent varicella
Decreased
B Cell
s or
Antibody
:
Hypogammaglobulinemia
IgA Deficiency (30% of U.S. cases and most common
B-Cell Disorder
overall in U.S.)
Low levels or absent IgA
Prone to respiratory or gastrointestinal infections
May be associated with IgG2 or IgG4 deficiency
IgG Subclass Deficiency of IgG2, IgG3, IgG4 (26% of U.S. cases)
Common Variable Immunodeficiency
or
CVID
(15% in U.S. and 46% in Europe of cases)
Bimodal onset in preschool and in young adults
Two
Immunoglobulin
subtypes are low (typically including Low total IgG, as well as IgM and IgA)
B-Cells may be decreased in number and have defective function (T Cells may also be defective)
Similar to
X-Linked Agammaglobulinemia
, but more mild
Ear, sinus and lung infections occur as with other
Antibody Disorder
s (e.g. pneumococcus, H.
Influenza
e)
CVID
also present with malabsorption from
Infectious Diarrhea
Examples: C. difficile,
Giardia
,
Salmonella
,
Campylobacter
,
Yersinia
Transient Hypogammaglobulinemia of Infancy
(3% of U.S. cases)
Increased mild
Bacteria
l respiratory infections
Normal nadir that corrects by age 2-4 years
Increased
Immunoglobulin
: Hypergammaglobulinemia
Hyper-
Immunoglobulin E
(IgE) Syndrome (
Job Syndrome
)
Significantly increased IgE levels
Skin disorders (e.g.
Eczema
) and infections
Recurrent lung infections (staphylococcal empyema)
Hyper-
Immunoglobulin M
or
Hyper-IgM Syndrome
(
HIGM
)
CD40
Ligand
deficiency (most common cause, X-Linked)
T-Lymphocyte
s are unable to trigger B-Cells to switch
Immunoglobulin
production of IgM to IgG, IgA and IgE
IgM levels increase, but other
Antibody
levels are deficient
Results in recurrent and severe infections (including opportunistic infections)
Results in increased malignancy risk
Causes
T-Cell Disorder
s (9-10% of Primary Immunodeficiency in both Europe and U.S.)
See
HIV Infection
(or
AIDS
)
Gene
ral
Most
T-Cell Disorder
s are mixed
T-Cell
and
B-Cell Disorder
s as B-Cells rely on
T-Cell
s
Severe Combined Immunodeficiency
(
SCID
)
Severe T cell deficiency causes
B Cell
dysfunction
X-Linked deficiency or
Autosomal Recessive
trait (1 in 100,000 live births in U.S.)
Subtypes include X-Linked
SCID
,
Autosomal Recessive
SCID
,
Adenosine
Deaminase Deficiency
Onset before age 3 months
Presents with
Diarrhea
, opportunistic infections, severe childhood infections and
Failure to Thrive
Specific infections include
Otitis Media
,
Mononucleosis
and
Candidiasis
Survival 90% with diagnosis and
Stem Cell Transplant
in first 3.5 months of life (contrast with 70% after that age)
Added to routine
Newborn Screening
panels in about one third of U.S. States as of 2013-14
False Positive
s 1.5% in term infants and 5%
Preterm Infant
s in NICU (will requires re-testing)
Ataxia Telangiectasia
Combined humoral and cell-mediated
Immunity
deficiency
Impaired DNA repair mechanisms result in IgA deficiency (and possibly IgG2 and IgE deficiency)
Onset of
Telangiectasia
by age 3-6 years old
Progressive
Ataxia
affecting disordered ambulation by age 10-12 years old
Recurrent sinus and lung infections, autoimmune disorders and malignancy (e.g.
Non-Hodgkin Lymphoma
)
Wiscott-Aldrich Syndrome
X-Linked disorder, typicalluy diagnosed around 21 months of age
Classic triad of
Thrombocytopenia
, recurrent
Otitis Media
and
Eczema
(present in only 27% of cases)
Thrombocytopenia
with life threatening bleeding (
GI Bleed
ing,
Intracranial Bleeding
) in up to 30% of children
DiGeorge Syndrome
(Velocardiofacial,
Congenital Thymic Aplasia
)
Deletion at 22q11.2 results in incomplete development from third and fourth pharyngeal pouches
Thymus
hypoplasia
Hypoparathyroidism
with
Hypocalcemia
Cardiac abnormalities and altered facial features
T
Lymphocyte
deficiency (low
T-Cell
numbers and decreased or absent
T-Cell
response)
Severe
Viral Infection
s from contagious spread or from
Live Vaccine
Persistent fungal infections (e.g.
Thrush
persists >12 months)
Causes
Phagocytic Disorders (8.5% of U.S. and 12.5% of European Primary Immunodeficiency cases)
Background
Phagocyte
s (
Neutrophil
s and
Macrophage
s) are critical to clearing infections
Gene
ral
Disorders of
Neutrophil
s or
Monocyte
s/
Macrophage
s
Fungal Lung Infection
s
Recurrent abscesses or delayed
Wound Healing
May present with invasive infections
Catalase positive infections (consider especially if invasive infections)
Staphylococcus aureus
Pseudomonas
Aspergillus
Burkholderia cepacia
Nocardia
Serratia
Candida
Neutropenia
- Decreased
Absolute Neutrophil Count
(ANC<500/ul)
Chemotherapy
-related
Neutropenia
Severe Congenital
Neutropenia
Presents in first few weeks of life
Omphalitis
Autoimmune
Neutropenia
Cyclic
Neutropenia
Neutrophil
numbers fluctuate in 21 day cycle
Decreased
Neutrophil
function
Chediak-Higashi Syndrome
Chronic Granulomatous Disease
(CGD)
Inherited
Phagocyte
NADPH
oxidase abnormality
Phagocyte
oxidase converts oxygen to Reactive Oxygen Intermediates (ROI)
Without ROIs (e.g. superoxide anions),
Phagocyte
s can not lyse and destroy engulfed
Microbe
s
Results in defect of PMN intracellular killing
Typically diagnosed by age 5 years old
May first present as omphalitis in infants
Recurrent in
Intracellular Bacteria
l and fungal infections, abscesses and
Granuloma
s
Examples:
Pneumonia
, abscesses, suppurative adenitis, gastrointestinal infections
Leukocyte
adhesion deficiency (type 1)
Adhesion molecules allow
Phagocyte
s to adhere to vascular endothelium and migrate to infection site
Leukocyte
adhesion deficiency presents in first few weeks of life
Delayed
Umbilical Cord
separation beyond 4 weeks after birth
Omphalitis
Other findings
Poor
Wound Healing
Erosive perianal ulcers
Severe
Bacterial Infection
s (e.g.
Pneumonia
, chronic
Skin Infection
s)
Causes
Complement Disorder
s: 2% of cases
Autoimmune Condition
or
Rheumatologic Condition
(associated with C1-C4 deficiencies)
Systemic Lupus Erythematosus
Recurrent encapsulated organism, esp. pyogenic infections (manifestations vary depending on missing complement type)
Complement deficiencies include C1q, C2-C9 (except C4), Factor I, Properdin
Neisseria
infections are most common including
Meningitis
,
Sepsis
and
Arthritis
(associated with C5-C9 deficiencies)
Recurrent infections with
Streptococcus Pneumoniae
and
Haemophilus
Influenza
e (associated with C3 deficiency)
Hereditary Angioedema
C1 Esterase Inhibitor Deficiency
Signs
Red Flags for Primary Immunodeficiency
Most helpful warning signs
Positive
Family History
of Immunodeficiency
History of
Sepsis
requiring intravenous
Antibiotic
s
Failure to Thrive
Subbarayan (2011) Pediatrics 127(5): 810-6 [PubMed]
Warning sign patterns
Increasing frequency and severity of infections as children become older (opposite of typical pattern)
Recurrent serious infections (at 2 or more sites) with common pathogens
Serious, invasive infections with uncommon pathogens
Recurrent and persistent infections
Otitis Media
(>8 episodes/year)
Or complicated by
Mastoiditis
Severe
Bacteria
l
Sinusitis
(>1 episode/year)
Pneumonia
(>1 episode/year)
Enteric infections (e.g.
Giardia
,
Cryptosporidium
)
Skin Abscess
es
Unusual sites of infection (e.g. liver,
Spleen
)
Opportunistic infections (e.g.
Aspergillus
,
Nocardia
)
Persistant
Thrush
after age 1 year
Infection despite >2 months of
Antibiotic
use
Infection clears only with
Parenteral
Antibiotic
s
Physical findings
Failure to Thrive
Miscellaneous
Family History
of Primary Immunodeficiency
Autoimmune Disease
(e.g. ITP or
Hemolytic Anemia
)
Differential Diagnosis
Asthma
or atopic condition
Cystic Fibrosis
Secondary Immunodeficiency
See Types section above
Labs
Initial Screening
Complete Blood Count
with manual differential
Screens for
T-Cell Disorder
s and Phagocytic disorders
See Absolute
Lymphocyte Count
discriminatory levels under
T-Cell Disorder
s below
Low
Neutrophil Count
(ANC <1500/mm3) may suggest cause for phagocytic disorder
Serum
Immunoglobulin
levels
Complement Levels
Complement C3
(Intrinsic and Extrinsic Pathway Function)
Complement C4
(Intrinsic Pathway Function, deficiency in 11% of SLE patients, 1% of U.S. population)
CH50 (Entire Intrinsic Pathway Function)
Peripheral Smear
Howell-Jolly
bodies suggests
Asplenism
HIV Test
Age 18 months or older
HIV Antibody
testing is sufficient
Age under 18 months
Obtain HIV DNA PCR or
HIV RNA
at age 14-21 days, age 1 month and age 4-6 months
Specific Immunodeficiency testing
B-Cell function and
Antibody
Tests (
Humoral Immunity
)
Step 1: Quantitative serum IgG, IgM, IgE and IgA levels
IgG subclasses (IgG 1-4) are usually not helpful
Low serum
Immunoglobulin
levels should prompt
Serum Albumin
testing
Hypoalbuminemia (e.g.
Proteinuria
or malabsorption) may cause secondary Immunodeficiency
Step 2: Response to
Vaccine
(if step 1
Immunoglobulin
levels are low)
Obtain pre-
Vaccine
titers
Administer
Vaccine
Encapsulated organism
Vaccine
s (H.
Influenza
e or Pneumococcus titers) if over age 2 years
Tetanus
,
Rubella
, Diptheria, or Mumps
Vaccine
at any age
Measure post-
Vaccine
titers at 4 weeks (3 weeks if two or more prior same antigen
Vaccination
s)
Expect 2 to 2.5 fold titer increase after
Vaccination
Failed titer increase suggests
Humoral Immunodeficiency
T-Cell
Function Tests
Absolute
Lymphocyte Count
(ALC, done in CBC)
Unlikely if normal
Lymphocyte Count
Newborn: <3000/mm3 suggests
T-Cell Disorder
Infant or child with ALC at 2 S.D. below mean suggests
T-Cell Disorder
(especially
SCID
)
Delayed-Type Hypersensitivity
(age >1 year old)
Intradermal Skin Test: Candida Albicans,
Mumps
or
Tetanus
Positive test rules-out
T-Cell
defects
Most cost-effective test for
T-Cell
dysfunction
Lymphocyte
subset analysis (percentage estimates)
T Cells (CD3, CD4, CD8)
B Cell
s (CD19, CD20)
Natural Killer Cell
s (CD16, CD56)
Phagocytosis
function tests
Absolute Neutrophil Count
(ANC) <1500/mm3
Granulocyte
function tests
Flow cytometry for
Neutrophil
oxidative burst
Complement function tests
Total complement or CH50 (test when well)
If abnormal, test alternative pathway (CH100 or AH50)
Management
See precautions below (
Vaccine
s,
Blood Product
s)
Avoid
Microorganism
exposure (e.g.
Face Mask
s in public)
Obtain
Genetic Counseling
if Primary Immunodeficiency identified
Prophylaxis
Prophylactic
Antibiotic
s
Intravenous Immunoglobulin
(IVIG) or
Subcutaneous Immunoglobulin
for specific
Humoral Immunodeficiency
Bone Marrow Transplant
Indications
Severe Combined Immunodeficiency
(
SCID
)
Chronic Granulomatous Disease
Precautions
Vaccine
s to avoid in patients and their close contacts
Oral Polio Vaccine
(
Live Vaccine
)
Varicella Vaccine
(
Live Vaccine
)
BCG vaccine
Measles
Vaccine
Blood Product
s
Specific precautions depending on condition
Resources
National Primary Immunodeficiency Resource Center
http://npi.jmfworld.org
Immune Deficiency Foundation
http://www.primaryimmune.org
References
Mahmoudi (2014)
Immunology
Made Ridiculously Simple, MedMaster, Miami, FL
Cooper (2003) Am Fam Physician 68:2001-11 [PubMed]
Reust (2013) Am Fam Physician 87(11): 773-8 [PubMed]
Rosen (1995) N Engl J Med 333(7):431-440 [PubMed]
Type your search phrase here